SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Sonia Kamath, Kimberly A. Miller, Myles G. Cockburn, Current Data on Risk Factor Estimates Does Not Explain the Difference in Rates of Melanoma between Hispanics and Non-Hispanic Whites, Journal of Skin Cancer, 2016, 2016, 1

    CrossRef

  2. 2
    A. Hunter Shain, Boris C. Bastian, From melanocytes to melanomas, Nature Reviews Cancer, 2016,

    CrossRef

  3. 3
    David E. Elder, Melanoma progression, Pathology, 2016, 48, 2, 147

    CrossRef

  4. 4
    Cliff O. Rosendahl, Jane M. Grant-Kels, Syril Keena T. Que, Dysplastic nevus: Fact and fiction, Journal of the American Academy of Dermatology, 2015, 73, 3, 507

    CrossRef

  5. 5
    David E. Elder, Point: What's in a name?, Journal of the American Academy of Dermatology, 2015, 73, 3, 513

    CrossRef

  6. 6
    P. Kaskel, U. Lange, S. Sander, M.A. Huber, J. Utikal, U. Leiter, G. Krähn, M. Meurer, M. Kron, Ultraviolet exposure and risk of melanoma and basal cell carcinoma in Ulm and Dresden, Germany, Journal of the European Academy of Dermatology and Venereology, 2015, 29, 1
  7. 7
    Michael Y. Xiong, Michael S. Rabkin, Michael W. Piepkorn, Raymond L. Barnhill, Zsolt Argenyi, Lori Erickson, Joan Guitart, Lori Lowe, Christopher R. Shea, Martin J. Trotter, Robert A. Lew, Martin A. Weinstock, Diameter of dysplastic nevi is a more robust biomarker of increased melanoma risk than degree of histologic dysplasia: A case-control study, Journal of the American Academy of Dermatology, 2014, 71, 6, 1257

    CrossRef

  8. 8
    Thomas L. Hocker, Ali Alikhan, Nneka I. Comfere, Margot S. Peters, Favorable long-term outcomes in patients with histologically dysplastic nevi that approach a specimen border, Journal of the American Academy of Dermatology, 2013, 68, 4, 545

    CrossRef

  9. 9
    Hebah Aboul-Fotouh, Lauren A Baker, Michelle Lucero Jackson, Clay J Cockerell, Reassessment of the dysplastic nevus concept in the 21st century: a proposal for a two-tiered system of classification, Clinical Investigation, 2013, 3, 12, 1105

    CrossRef

  10. 10
    Anna Maria Cesinaro, Clinico-pathological impact of fibroplasia in melanocytic nevi: a critical revision of 209 cases, APMIS, 2012, 120, 8
  11. 11
    Michele J. Farber, Edward R. Heilman, Robert J. Friedman, Dysplastic Nevi, Dermatologic Clinics, 2012, 30, 3, 389

    CrossRef

  12. 12
    Michael Campoli, James E. Fitzpatrick, Whitney High, Soldano Ferrone, HLA antigen expression in melanocytic lesions: Is acquisition of HLA antigen expression a biomarker of atypical (dysplastic) melanocytes?, Journal of the American Academy of Dermatology, 2012, 66, 6, 911

    CrossRef

  13. 13
    Stewart F Cramer, Andrey Fesyuk, On the Development of Neurocutaneous Units—Implications for the Histogenesis of Congenital, Acquired, and Dysplastic Nevi, The American Journal of Dermatopathology, 2012, 34, 1, 60

    CrossRef

  14. You have free access to this content14
    Clara Curiel-Lewandrowski, Susan M. Swetter, Janine G. Einspahr, Chiu-Hsieh Hsu, Ray Nagle, Paul Sagerman, Joseph Tangrea, Howard Parnes, David S. Alberts, Hsiao-Hui Chow, Randomized, double-blind, placebo-controlled trial of sulindac in individuals at risk for melanoma, Cancer, 2012, 118, 23
  15. 15
    Keith Duffy, Douglas Grossman, The dysplastic nevus: From historical perspective to management in the modern era, Journal of the American Academy of Dermatology, 2012, 67, 1, 1.e1

    CrossRef

  16. 16
    Loren E. Clarke, Dysplastic Nevi, Clinics in Laboratory Medicine, 2011, 31, 2, 255

    CrossRef

  17. 17
    Marija Marinkovic, Zlata Janjic, Jelena Nikolic, Dysplastic nevus - a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature, Medicinski pregled, 2011, 64, 5-6, 315

    CrossRef

  18. 18
    Ehab A Husain, Charles Mein, Lucia Pozo, Alfredo Blanes, Salvador J Diaz-Cano, Heterogeneous topographic profiles of kinetic and cell cycle regulator microsatellites in atypical (dysplastic) melanocytic nevi, Modern Pathology, 2011, 24, 4, 471

    CrossRef

  19. 19
    Michael Campoli, Soldano Ferrone, HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition, Seminars in Immunopathology, 2011, 33, 4, 321

    CrossRef

  20. 20
    Jennifer Nam Choi, Allison Hanlon, David Leffell, Melanoma and Nevi: Detection and Diagnosis, Current Problems in Cancer, 2011, 35, 4, 138

    CrossRef

  21. You have free access to this content21
    Estee L. Psaty, Alon Scope, Allan C. Halpern, Ashfaq A. Marghoob, Defining the patient at high risk for melanoma, International Journal of Dermatology, 2010, 49, 4
  22. You have free access to this content22
    David E Elder, Dysplastic naevi: an update, Histopathology, 2010, 56, 1
  23. 23
    E. Tan, A. Oakley, H.P. Soyer, M. Haskett, A. Marghoob, M. Jameson, M. Rademaker, Interobserver variability of teledermoscopy: an international study, British Journal of Dermatology, 2010, 163, 6
  24. 24
    Kristen DeCarlo, Shi Yang, Andrew Emley, Narendra Wajapeyee, Michael Green, Meera Mahalingam, Oncogenic BRAF-positive dysplastic nevi and the tumor suppressor IGFBP7—challenging the concept of dysplastic nevi as precursor lesions?, Human Pathology, 2010, 41, 6, 886

    CrossRef

  25. 25
    Matthew G. Fleming, Pigmented Lesion Pathology: What You Should Expect from Your Pathologist, and What Your Pathologist Should Expect from You, Clinics in Plastic Surgery, 2010, 37, 1, 1

    CrossRef

  26. 26
    David E Elder, Response to ‘Dysplastic naevi, again’, Histopathology, 2010, 57, 2
  27. 27
    Carlos A. Torres-Cabala, Jose A. Plaza, A. Hafeez Diwan, Victor G. Prieto, Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions, Journal of Cutaneous Pathology, 2010, 37, 8
  28. 28
    Raymond L. Barnhill, Lorenzo Cerroni, Martin Cook, David E. Elder, Helmut Kerl, Philip E. LeBoit, Stanley W. McCarthy, Martin C. Mihm, Wolter J. Mooi, Michael W. Piepkorn, Victor G. Prieto, Richard A. Scolyer, State of the Art, Nomenclature, and Points of Consensus and Controversy Concerning Benign Melanocytic Lesions: Outcome of an International Workshop, Advances in Anatomic Pathology, 2010, 17, 2, 73

    CrossRef

  29. 29
    Loren E. Clarke, Dysplastic Nevi, Surgical Pathology Clinics, 2009, 2, 3, 447

    CrossRef

  30. 30
    A.B. Alexandroff, R. Burd, Footprints of the EADV: a meeting report from the 17th Congress of the European Academy of Dermatology and Venereology, British Journal of Dermatology, 2009, 160, 5
  31. 31
    Robert J. Friedman, Michele J. Farber, Melanie A. Warycha, Nicole Papathasis, Michael K. Miller, Edward R. Heilman, The “dysplastic” nevus, Clinics in Dermatology, 2009, 27, 1, 103

    CrossRef

  32. 32
    A.M. Morales-Callaghan, J. Castrodeza-Sanz, G. Martínez-García, I. Peral-Martínez, A. Miranda-Romero, Correlation Between Clinical, Dermatoscopic, and Histopathologic Variables in Atypical Melanocytic Nevi, Actas Dermo-Sifiliográficas (English Edition), 2008, 99, 5, 380

    CrossRef

  33. 33
    A.M. Morales-Callaghan, J. Castrodeza-Sanz, G. Martínez-García, I. Peral-Martínez, A. Miranda-Romero, Estudio de correlación clínica, dermatoscópica e histopatológica de nevus melanocíticos atípicos, Actas Dermo-Sifiliográficas, 2008, 99, 5, 380

    CrossRef

  34. 34
    Michael S. Rabkin, The limited specificity of histological examination in the diagnosis of dysplastic nevi, Journal of Cutaneous Pathology, 2008, 35,
  35. 35
    Raymond L. Barnhill, Stephen Vernon, Harold S. Rabinovitz, Color Atlas of Dermatopathology, 2007,

    CrossRef

  36. 36
    Research Snippets, Journal of Investigative Dermatology, 2006, 126, 12, 2558

    CrossRef

  37. 37
    Varun Shahi, Jerry D. Brewer, Melanocytic Nevi,